Dolutegravir rollout for treatment of HIV with a focus on advanced disease and tuberculosis coinfection: findings from rural KwaZulu-Natal, South Africa (2019–2023)

Abstract Background While Dolutegravir (DTG) containing antiretroviral therapy (ART) has become the preferred regimen for people living with HIV (PLHIV), the pace and equity of its adoption, especially among subgroups with tuberculosis (TB) symptoms and advanced HIV disease (AHD), remain understudie...

Cijeli opis

Bibliografski detalji

Glavni autori:	Reuben Christopher Moyo, Larisse Bolton, Elphas Luchemo Okango, Margot Otto, Nthoesele Letoao, Peter Suwirakwenda Nyasulu, Frank Tanser
Format:	Artigo
Jezik:	Inglês
Izdano:	BMC 2025-10-01
Serija:	AIDS Research and Therapy
Teme:	Tuberculosis Advanced HIV disease Dolutegravir South Africa
Online pristup:	https://doi.org/10.1186/s12981-025-00810-z
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!